Quarterly report · Q3

Period2023-04-01 → 2023-12-31
Filed2024-02-08
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥4.4bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥5.2bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥3.9bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥773m2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥734m2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥717m2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥1.0bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥746m2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥717m2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥640m2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥461m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥574m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥414m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥461m2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥414m2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥6.4bnat 2023-12-31Cons.Assets
Total assets¥5.8bnat 2023-03-31Cons.Assets
Total assets¥5.7bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥2.0bnat 2023-12-31Cons.Liabilities
Total liabilities¥1.7bnat 2023-03-31Cons.Liabilities
Net assets / equity¥4.4bnat 2023-12-31Cons.Net assets
Net assets / equity¥4.1bnat 2023-03-31Cons.Net assets
Net assets / equity¥4.0bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥3.8bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥3.7bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥39.252023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥13.682023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥48.682022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥35.052022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥6.472022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥38.552023-04-01 → 2023-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥47.572022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥34.22022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio68.5%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio70.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio70.1%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 43
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-12-31¥600,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-12-31¥600,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31¥300,000
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥28m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥28m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥258m
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue2023-04-01 → 2023-12-31¥3.2bn
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue external2023-04-01 → 2023-12-31¥3.2bn
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥26m
jpcrp040300-q3r_E32408-000Globalreportable segmentsegment profit2023-04-01 → 2023-12-31¥290m
jpcrp040300-q3r_E32408-000Medicalreportable segmentrevenue2023-04-01 → 2023-12-31¥1.2bn
jpcrp040300-q3r_E32408-000Medicalreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.2bn
jpcrp040300-q3r_E32408-000Medicalreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥3m
jpcrp040300-q3r_E32408-000Medicalreportable segmentsegment profit2023-04-01 → 2023-12-31¥741m
—segment totalrevenue2023-04-01 → 2023-12-31¥4.4bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥4.4bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥28m
—segment totalsegment profit2023-04-01 → 2023-12-31¥1.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥4.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥4.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥28m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥1.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥300,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥300,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥150,000
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥33m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥33m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥240m
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue2022-04-01 → 2022-12-31¥2.8bn
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue external2022-04-01 → 2022-12-31¥2.8bn
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥33m
jpcrp040300-q3r_E32408-000Globalreportable segmentsegment profit2022-04-01 → 2022-12-31¥312m
jpcrp040300-q3r_E32408-000Medicalreportable segmentrevenue2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E32408-000Medicalreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E32408-000Medicalreportable segmentsegment profit2022-04-01 → 2022-12-31¥662m
—segment totalrevenue2022-04-01 → 2022-12-31¥3.9bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥3.9bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥33m
—segment totalsegment profit2022-04-01 → 2022-12-31¥974m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥33m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥974m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 347
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)EY新日本有限責任監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)原  山  精  一
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)天  野  清  彦
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration3910774000JPY
Net sales (5-year summary)CurrentYTDDuration4397927000JPY
Net sales (5-year summary)Prior1YearDuration5246671000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration746473000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration716655000JPY
Ordinary income loss (5-year summary)Prior1YearDuration1004024000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YTDDuration413582000JPY
Profit loss attributable to owners of parent (5-year summary)CurrentYTDDuration461437000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration573793000JPY
Comprehensive income (5-year summary)Prior1YTDDuration397957000JPY
Comprehensive income (5-year summary)CurrentYTDDuration400653000JPY
Comprehensive income (5-year summary)Prior1YearDuration632818000JPY
Net assets (5-year summary)Prior1QuarterInstant3973261000JPY
Net assets (5-year summary)CurrentQuarterInstant4384870000JPY
Net assets (5-year summary)Prior1YearInstant4090409000JPY
Total assets (5-year summary)Prior1QuarterInstant5669871000JPY
Total assets (5-year summary)CurrentQuarterInstant6385532000JPY
Total assets (5-year summary)Prior1YearInstant5797219000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration35.05
Basic earnings loss per share (5-year summary)CurrentYTDDuration39.25
Basic earnings loss per share (5-year summary)Prior1YearDuration48.68
Diluted earnings per share (5-year summary)Prior1YTDDuration34.20
Diluted earnings per share (5-year summary)CurrentYTDDuration38.55
Diluted earnings per share (5-year summary)Prior1YearDuration47.57
Equity to asset ratio (5-year summary)Prior1QuarterInstant0.701
Equity to asset ratio (5-year summary)CurrentQuarterInstant0.685
Equity to asset ratio (5-year summary)Prior1YearInstant0.706
Basic earnings loss per share (5-year summary)Prior1QuarterDuration6.47
Basic earnings loss per share (5-year summary)CurrentQuarterDuration13.68
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember11891920
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember11903920
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant11891920
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant11903920
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember126600
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember117585
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember11758500
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember6820
Number of shares issued shares voting rightsCurrentQuarterInstant11891920
Number of voting rights issued shares voting rightsCurrentQuarterInstant117585
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member126600
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass